Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angus C Nairn

Showing results (1-10 of 248) with videos related to

Pageof 25
Sort By:
Current Protocols in Molecular Biology|October 5, 2010
Serine/threonine protein phosphatase assaysThomas McAvoy, Angus C Nairn
Brain Research|September 1, 2015
Contrasting features of ERK1/2 activity and synapsin I phosphorylation at the ERK1/2-dependent site in the rat brain in status epilepticus induced by kainic acid in vivoYoko Yamagata, Angus C Nairn
Proteomes|June 5, 2019
Editorial for Special Issue: NeuroproteomicsKenneth R Williams, Angus C Nairn
Biochimica Et Biophysica Acta. Molecular Cell Research|November 8, 2018
cAMP regulation of protein phosphatases PP1 and PP2A in brainShannon N Leslie, Angus C Nairn
Advances in Pharmacology (San Diego, Calif.)|March 12, 2021
DARPP-32 40 years laterJean-Antoine Girault, Angus C Nairn
The European Journal of Neuroscience|November 17, 2007
Expression of PKC substrate proteins, GAP-43 and neurogranin, is downregulated by cAMP signaling and alterations in synaptic activityDilja D Krueger, Angus C Nairn
Advances in Pharmacology (San Diego, Calif.)|March 12, 2021
cAMP-regulated phosphoproteins DARPP-32, ARPP16/19, and RCS modulate striatal signal transduction through protein kinases and phosphatasesKyle R Christensen, Angus C Nairn
Proteomes|December 15, 2018
Cell-Type-Specific Proteomics: A Neuroscience PerspectiveRashaun S Wilson, Angus C Nairn
Nature Biotechnology|February 7, 2018
Making brain proteomics true to typeRashaun S Wilson, Angus C Nairn
The AAPS Journal|December 16, 2005
DARPP-32 mediates the actions of multiple drugs of abusePer Svenningsson, Angus C Nairn, Paul Greengard
Pageof 25

Showing results (1-10 of 248) with videos related to

Sort By:
Pageof 25
Current Protocols in Molecular Biology|October 5, 2010
Serine/threonine protein phosphatase assaysThomas McAvoy, Angus C Nairn
Brain Research|September 1, 2015
Contrasting features of ERK1/2 activity and synapsin I phosphorylation at the ERK1/2-dependent site in the rat brain in status epilepticus induced by kainic acid in vivoYoko Yamagata, Angus C Nairn
Proteomes|June 5, 2019
Editorial for Special Issue: NeuroproteomicsKenneth R Williams, Angus C Nairn
Biochimica Et Biophysica Acta. Molecular Cell Research|November 8, 2018
cAMP regulation of protein phosphatases PP1 and PP2A in brainShannon N Leslie, Angus C Nairn
Advances in Pharmacology (San Diego, Calif.)|March 12, 2021
DARPP-32 40 years laterJean-Antoine Girault, Angus C Nairn
The European Journal of Neuroscience|November 17, 2007
Expression of PKC substrate proteins, GAP-43 and neurogranin, is downregulated by cAMP signaling and alterations in synaptic activityDilja D Krueger, Angus C Nairn
Advances in Pharmacology (San Diego, Calif.)|March 12, 2021
cAMP-regulated phosphoproteins DARPP-32, ARPP16/19, and RCS modulate striatal signal transduction through protein kinases and phosphatasesKyle R Christensen, Angus C Nairn
Proteomes|December 15, 2018
Cell-Type-Specific Proteomics: A Neuroscience PerspectiveRashaun S Wilson, Angus C Nairn
Nature Biotechnology|February 7, 2018
Making brain proteomics true to typeRashaun S Wilson, Angus C Nairn
The AAPS Journal|December 16, 2005
DARPP-32 mediates the actions of multiple drugs of abusePer Svenningsson, Angus C Nairn, Paul Greengard
Pageof 25